Read Full Article
(Insmed), to Xilio's board of directors . “I am very pleased to welcome Sara to our board of directors ,” said Dan Lynch, chairman of the board of directors of ...
I am very pleased to welcome Sara to our board of directors.
The significant progress Xilio has made in the first half of this year is impressive, with encouraging preclinical data across a number of cytokine and antibody programs and FDA clearance of the company's first Investigational New Drug application.